Boston Scientific Corp Stock Performance
| BSX Stock | USD 73.17 0.09 0.12% |
On a scale of 0 to 100, Boston Scientific holds a performance score of 17. The firm shows a Beta (market volatility) of 0.49, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Boston Scientific's returns are expected to increase less than the market. However, during the bear market, the loss of holding Boston Scientific is expected to be smaller as well. Please check Boston Scientific's value at risk, as well as the relationship between the kurtosis and market facilitation index , to make a quick decision on whether Boston Scientific's price patterns will revert.
Risk-Adjusted Performance
17 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Boston Scientific Corp are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Boston Scientific showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.92) | Five Day Return (0.88) | Year To Date Return 25.35 | Ten Year Return 469.52 | All Time Return 1.6 K |
Last Split Factor 2:1 | Last Split Date 2003-11-06 |
1 | Disposition of 1644 shares by Daniel Brennan of Boston Scientific at 65.82 subject to Rule 16b-3 | 02/16/2024 |
2 | Shockwave medical stock gains as JJ deal makes sense | 03/27/2024 |
3 | Boston Scientific stock target raised by Argus | 04/03/2024 |
4 | Nectero Medical Announces Completion of 96M Series D Financing | 04/11/2024 |
5 | Abbott looks to highly productive device pipeline for future growth | 04/17/2024 |
6 | FDA Classifies Boston Scientifics Recall For Device To Stop Blood Flow As Most Serious | 04/18/2024 |
7 | Unveiling Boston Scientific Q1 Outlook Wall Street Estimates for Key Metrics | 04/19/2024 |
8 | Neuromod startup IVEAcare raises 27.5M, names CEO | 04/22/2024 |
9 | Boston Scientific Gets IBD Stock Rating Upgrade | 04/23/2024 |
10 | Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars | 04/24/2024 |
11 | Boston Scientific Corporation Q1 2024 Earnings Call Transcript | 04/25/2024 |
12 | United States Interventional Radiology Products Market Projected to Reach USD 17.01 billion By 2030, With 6.7 percent CAGR | 04/26/2024 |
| Begin Period Cash Flow | 1.1 B |
Boston |
Boston Scientific Relative Risk vs. Return Landscape
If you would invest 6,142 in Boston Scientific Corp on January 30, 2024 and sell it today you would earn a total of 1,116 from holding Boston Scientific Corp or generate 18.17% return on investment over 90 days. Boston Scientific Corp is generating 0.2682% of daily returns assuming volatility of 1.1995% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than Boston, and above 95% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Boston Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Boston Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Boston Scientific Corp, and traders can use it to determine the average amount a Boston Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2236
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BSX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.2 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.22 actual daily | 17 83% of assets perform better |
Based on monthly moving average Boston Scientific is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Boston Scientific by adding it to a well-diversified portfolio.
Boston Scientific Fundamentals Growth
Boston Stock prices reflect investors' perceptions of the future prospects and financial health of Boston Scientific, and Boston Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Boston Stock performance.
| Return On Equity | 0.0858 | ||||
| Return On Asset | 0.0447 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 116.3 B | ||||
| Shares Outstanding | 1.47 B | ||||
| Price To Earning | 107.05 X | ||||
| Price To Book | 5.19 X | ||||
| Price To Sales | 7.03 X | ||||
| Revenue | 14.24 B | ||||
| Gross Profit | 8.68 B | ||||
| EBITDA | 3.62 B | ||||
| Net Income | 1.59 B | ||||
| Cash And Equivalents | 928 M | ||||
| Cash Per Share | 0.24 X | ||||
| Total Debt | 9.49 B | ||||
| Debt To Equity | 0.51 % | ||||
| Current Ratio | 1.45 X | ||||
| Book Value Per Share | 13.15 X | ||||
| Cash Flow From Operations | 2.5 B | ||||
| Earnings Per Share | 1.19 X | ||||
| Market Capitalization | 107.55 B | ||||
| Total Asset | 35.14 B | ||||
| Retained Earnings | 819 M | ||||
| Working Capital | 1.58 B | ||||
| Current Asset | 1.21 B | ||||
| Current Liabilities | 923 M | ||||
About Boston Scientific Performance
To evaluate Boston Scientific Corp Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Boston Scientific generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Boston Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Boston Scientific Corp market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Boston's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 208.67 | 167.64 | |
| Return On Tangible Assets | 0.11 | 0.11 | |
| Return On Capital Employed | 0.08 | 0.14 | |
| Return On Assets | 0.05 | 0.05 | |
| Return On Equity | 0.08 | 0.06 |
Things to note about Boston Scientific Corp performance evaluation
Checking the ongoing alerts about Boston Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Boston Scientific Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Boston Scientific is unlikely to experience financial distress in the next 2 years | |
| Over 94.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from kalkinemedia.com: United States Interventional Radiology Products Market Projected to Reach USD 17.01 billion By 2030, With 6.7 percent CAGR |
- Analyzing Boston Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Boston Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Boston Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Boston Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Boston Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Boston Scientific's stock. These opinions can provide insight into Boston Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Boston Scientific Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Boston Stock analysis
When running Boston Scientific's price analysis, check to measure Boston Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Boston Scientific is operating at the current time. Most of Boston Scientific's value examination focuses on studying past and present price action to predict the probability of Boston Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Boston Scientific's price. Additionally, you may evaluate how the addition of Boston Scientific to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Boston Scientific's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Boston Scientific. If investors know Boston will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Boston Scientific listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.579 | Earnings Share 1.19 | Revenue Per Share 10.065 | Quarterly Revenue Growth 0.138 | Return On Assets 0.0447 |
The market value of Boston Scientific Corp is measured differently than its book value, which is the value of Boston that is recorded on the company's balance sheet. Investors also form their own opinion of Boston Scientific's value that differs from its market value or its book value, called intrinsic value, which is Boston Scientific's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Boston Scientific's market value can be influenced by many factors that don't directly affect Boston Scientific's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Boston Scientific's value and its price as these two are different measures arrived at by different means. Investors typically determine if Boston Scientific is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Boston Scientific's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.